CONTEXT: BMJ article describing a framework for RWE study design toencourage reproducibility. The framework is intended for use in studieslooking at effectiveness and safety of medical products and claims to Continue Reading
CONTEXT: Oncology news article on use of RWR in oncology. Nothing new in terms of data use, more confirmation of RWD in oncology research. However, an interesting perspective from the Continue Reading
CONEXT: Denmark | De-Centralised Trials | Regulatory Update | RWR and Regulators | RWR IMPACT: Regulator endorsed initiative for de-centralised trials|Making clinical research results more ‘real’ READ TIME: 2.5 mins Continue Reading
CONTEXT: RWR & Regulators | Regulatory Updates | RWR | Ireland | Retrospective Chart Reviews IMPACT: High = New regulatory framework to support (improve?) the conduct of retrospective chart reviews Continue Reading
Quick Notes: CONTEXT: Europe Healthcare IT Market, Market Forecast and Analysis IMPACT: Expansion of IoT in the Healthcare Field and promise of new and exciting strategies for upcoming products by Continue Reading
Quick Notes: CONTEXT: RWD, RWE, Pfizer, Isaeli Government, Data Transparency, Real-World Epidemiological Evidence Collaboration Agreement IMPACT: Sharing of Real-World Epidemiological Evidence to improve understanding of impact of COVID-19 vaccination Time Continue Reading
Quick Notes: CONTEXT: USA, IVDs, RWE, Real-World Evidence Framework for regulatory decision-making for in vitro diagnostics (IVDs) IMPACT: step forward in providing the valuable information that IVD manufacturers and others Continue Reading
EXPERT NOTES: CONTEXT: EU, Commercial RWD Data Source IMPACT: Access to EU RWD, drive cutting edge improvements in patient outcome Time Taken = 3 mins QUOTES FROM SOURCE: 1. “NEW Continue Reading
EXPERT NOTES: CONTEXT: Peer Reviewed Data, RWE of Effectiveness of Cabozantinib IMPACT: In the largest real-world study to date, cabozantinib was effective in unselected, heavily pretreated patients with mRCC. Initiation Continue Reading
EXPERT NOTES: CONTEXT: Decentralized Clinical Trials IMPACT: Enabling technology for ‘Decentralized Clinical Trials’ a.k.a ‘Virtual Trials’ Time Taken = 2 mins QUOTES FROM SOURCE: 1. “As mentioned earlier, COVID-19 has Continue Reading
